Peptide · Synthetic dipeptide

Vilon

Research peptide
Aliases · KE peptide · Lys-Glu

A synthetic dipeptide promoted for immune, thymic and healthy-ageing effects, supported mainly by preclinical and regional literature.

Human
0/5
Animal
2/5
In-vitro
0/5
Safety
0/5
Last reviewed · 7/12/2026
Compare with another peptide →
Last reviewed7/12/2026
Evidence statusEarly entry
Published references0
Trust signal panel
Evidence & safety
  • Human evidence
    n/a
  • Animal evidence
    n/a
  • Mechanistic
    n/a
  • Safety knowledge
    n/a
  • Editorial confidence
    2/5
View in knowledge graph →See this peptide connected to conditions & mechanisms
01

Evidence Snapshot

Evidence snapshot · 1 verified ref
Overall
2/5Emerging / preliminary
Human
0/5None identified
Animal
2/5Some animal evidence
In-vitro
0/5None identified
Safety
0/5None identified
02

Scientific identity

Molecular formula
C11H21N3O5
Molecular weight
275.30 Da
Sequence
Lys-Glu
Peptide family
Khavinson short peptide bioregulator
Entity class
Synthetic dipeptide
Alternative names
KE peptideLys-Glu
Discovery history

Developed as a synthetic Lys-Glu dipeptide associated with thymic and immune bioregulator research.

02

Proposed Mechanisms

03

Reported / Studied Uses

04

Human Evidence

Human evidence is sparse, methodologically uncertain and not independently replicated at modern clinical-trial standards.

05

Animal Evidence

Animal studies report immune, tumour and lifespan-related effects that have not been confirmed clinically.

Species translation to humans is uncertain.
06

Safety & Unknowns

short-peptide-bioregulatorpreclinical-evidencelimited-independent-replicationunapproved-product
Long-term safety, interactions, immune effects and pharmaceutical-quality assurance are unknown.
07

Regulatory Status

CountryStatusNotes
08

Community Observations

No approved community reports yet. Submit one. Aggregate data is observational only.
09

References

  • No verified references linked yet. Editors will add primary sources.
10

Full Disclaimer

This page is for educational information only. It does not constitute medical advice, diagnosis, treatment, dosing guidance, or a recommendation to use any peptide, medicine or research chemical. Many peptides discussed on Atlas are not approved for human use in most jurisdictions and may have limited or unknown long-term safety data.

Community observations shown on this page are anonymised, moderated and observational only. They do not establish safety or effectiveness.

Always consult a qualified healthcare professional before making decisions about your health. See medical disclaimer and methodology.

Explore further

from the knowledge graph
ImportantPeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.